en

PRODUCT DETAIL

Lopinavir/Ritonavir Mylan 100 mg/25 mg filmom obalené tablety

Code 8289B
MA number EU/1/15/1067/002
Product Form: tbl flm 60x1x100 mg/25 mg (blis.OPA/Al/PVC/Al-perf.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR10 Lopinavir and Ritonavir
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 14.01.2016
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.11.2020
eu-flag.png sk-flag.png